Hiromichi Ishiyama

7PUBLICATIONS
23CO-AUTHORS
Environmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyInstruments and techniquesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 14, 2025
Clinical Outcomes and Prognostic Factors for Extramammary Paget's Disease Treated with Radiation Therapy: A Multi-Institutional Observational Study.

Masanari Niwa, Natsuo Tomita, Hiromichi Ishiyama

|Sep 09, 2023
Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer.

Hiroshi Onishi, Yoshiyuki Shioyama, Yasuo Matsumoto

|May 26, 2023
Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients.

Kyohei Fujii, Masahiro Nakano, Shogo Kawakami

|Apr 05, 2022
A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer.

S Kawakami, H Tsumura, T Satoh

|Mar 10, 2022
Radiosensitization Effect of Gold Nanoparticles on Plasmid DNA Damage Induced by Therapeutic MV X-rays.

Katsunori Yogo, Masaki Misawa, Hidetoshi Shimizu

|Jun 16, 2020
Size of pelvic bone metastasis as a significant prognostic factor for metastatic prostate cancer patients.

Toyokazu Hayakawa, Ken-Ichi Tabata, Hideyasu Tsumura

Pageof 2

Frequent Collaborators

2 joint publications

Satoshi Kametaka

1 joint publications

Hidetoshi Shimizu

1 joint publications

Ryoichi Hirayama

1 joint publications

Hiroshi Yasuda